Against this background, we conducted the Progressive Resistance Training and Cancer Testis (PROTRACT) study to explore two major questions: (I) the effects of BEP therapy on muscle function and (II) the efficacy of RT to prevent and/or mitigate anticipated therapy-induced muscle dysfunction in GCC patients.
In the present study, we investigated these markers, the HCC-associated marker AFP and other liver enzymes to identify pre- or post-treatment variables that may anticipate therapy response already in the early treatment phase.
Based on these animal studies, it was anticipated that therapies directed against VEGF-A or VEGFR-2 would open a new phase of therapy against human cancers.
In the spirit of the applied conceptual framework, features which are known to decrease efficiency of any evolutionary optimization procedure (or inhibit it completely) are anticipated as "therapies" and reviewed.
Increasing the length of therapy for the anticipated all oral therapy for genotype 1 24 weeks resulted in a cost increase for all oral therapy vs. SOC.
Anticipated Results: It is anticipated that calcitriol therapy will raise basal RPF and increase the RPF sensitivity to angiotensin II, thereby demonstrating that VDR activation improves renal-vascular hemodynamics by lowering local renal-vascular RAS activity in human diabetics without CKD.
Although rehabilitation therapy is considered important for TBI, it is anticipated that regenerative therapy will soon be available as a promising treatment for these patients.
It is anticipated that future therapy for breast cancer may involve targeting various HER receptors, their ligands [37] as well as metalloproteinases that mediate the cleavage of the ligands [43].
It is anticipated that HFNC therapy will be cost saving to the health system.
Where clinically significant risk is anticipated with combination therapy, this is typically minimized by recommending down-titration of the existing agent to coincide with the addition of the new agent.
Based on our previous experiments on lung cancer cell lines [ 3] and other studies [ 5, 6], we anticipated that insulin therapy would regulate the expression of pulmonary surfactant-associated genes.
